欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0231/001
药品名称LORISTA H 100 mg/12.5 mg
活性成分
    • Hydrochlorothiazide 12.5 mg
    • Losartan 100.0 mg
剂型Film-coated tablet
上市许可持有人Krka d.d., Novo mesto, Novo mesto,Slovenia
参考成员国 - 产品名称Czechia (CZ)
互认成员国 - 产品名称
    • Germany (DE)
      Losartan-Kalium HCTad 100mg/12,5mg Filmtabletten
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Losartan/HCT Krka 100 mg/12,5 mg Filmtabletten
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Lorista H 100 mg/12,5 mg plėvele dengtos tabletės
    • Estonia (EE)
      LORISTA H 100MG/12,5MG
    • Hungary (HU)
      LAVESTRA H 100 mg/12,5 mg filmtabletta
    • Bulgaria (BG)
      Lorista HL
    • Iceland (IS)
    • Cyprus (CY)
      LOSARTAN /HCT KRKA 100mg/12,5mg FC TABS
    • Romania (RO)
      Lorista HL 100 mg / 12,5 mg comprimate filmate
    • Slovakia (SK)
      Lorista H 100 mg/ 12,5 mg
许可日期2010/07/16
最近更新日期2025/01/20
药物ATC编码
    • C09DA01 losartan and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase